Literature DB >> 1347794

Stimulation of lymphokines in Jurkat cells persistently infected with vaccinia virus.

K A Stellrecht1, K Sperber, B G Pogo.   

Abstract

The response of the human CD4+ T-cell line Jurkat to infection with vaccinia virus was investigated. Virus titers peaked approximately 3 to 4 days after infection, while cell growth paralleled that of uninfected cells, indicating that growth rates were not appreciably affected by viral infection. Results from plaque assays and fluorescence-activated cell sorter (FACS) analyses of virus antigens demonstrated that a persistent infection in which the percentage of infected cells and the virus titers fluctuated from passage to passage was established. Further characterization of the persistent infection revealed that the virus influences cellular functions. Induction of interleukin-2 (IL-2) and IL-2 receptor alpha (IL-2R alpha) in Jvac cells was shown by enzyme-linked immunosorbent assay and FACS analysis, respectively. Hybridization of cellular RNA with cloned probes confirmed the increased IL-2 expression and demonstrated that Jvac cells also expressed more IL-6 but not gamma interferon (IFN-gamma) or IL-1 beta. Dual-antibody staining and FACS analysis for vaccinia virus antigens and IL-2R alpha indicated that IL-2R alpha expression was restricted to the infected cells. Jvac cells were also resistant to superinfection, an additional proof that persistent infection elicited phenotypic changes in the cell population.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1347794      PMCID: PMC288994     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  25 in total

Review 1.  Cooperation between oncogenes.

Authors:  T Hunter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

2.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

3.  Cell proliferative response to vaccinia virus is mediated by VGF.

Authors:  R M Buller; S Chakrabarti; B Moss; T Fredrickson
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

4.  Role of DNA replication in vaccinia virus gene expression: a naked template is required for transcription of three late trans-activator genes.

Authors:  J G Keck; C J Baldick; B Moss
Journal:  Cell       Date:  1990-06-01       Impact factor: 41.582

5.  The retinoblastoma protein is phosphorylated during specific phases of the cell cycle.

Authors:  K Buchkovich; L A Duffy; E Harlow
Journal:  Cell       Date:  1989-09-22       Impact factor: 41.582

6.  Role of the host cell in persistent viral infection: coevolution of L cells and reovoirus during persistent infection.

Authors:  R Ahmed; W M Canning; R S Kauffman; A H Sharpe; J V Hallum; B N Fields
Journal:  Cell       Date:  1981-08       Impact factor: 41.582

7.  Vaccinia virus DNA sequences in the nucleus of persistently infected Friend erythroleukemia cells.

Authors:  K M Obom; S W Popple; J G Holland; B G Pogo; C Friend
Journal:  Virus Res       Date:  1986-08       Impact factor: 3.303

8.  Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein.

Authors:  G J Kotwal; A W Hügin; B Moss
Journal:  Virology       Date:  1989-08       Impact factor: 3.616

9.  The same inducible nuclear proteins regulates mitogen activation of both the interleukin-2 receptor-alpha gene and type 1 HIV.

Authors:  E Böhnlein; J W Lowenthal; M Siekevitz; D W Ballard; B R Franza; W C Greene
Journal:  Cell       Date:  1988-06-03       Impact factor: 41.582

Review 10.  Cellular proteins that are targetted by DNA tumor viruses for transformation.

Authors:  N Dyson; K Buchkovich; P Whyte; E Harlow
Journal:  Princess Takamatsu Symp       Date:  1989
View more
  4 in total

1.  Activation of the human immunodeficiency virus type 1 long terminal repeat by vaccinia virus.

Authors:  K A Stellrecht; K Sperber; B G Pogo
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

2.  IL-7 enhancement of antigen-driven activation/expansion of HIV-1-specific cytotoxic T lymphocyte precursors (CTLp).

Authors:  G Ferrari; K King; K Rathbun; C A Place; M V Packard; J A Bartlett; D P Bolognesi; K J Weinhold
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

3.  Production and secretion of interferon-gamma (IFN-gamma) in children with atopic dermatitis.

Authors:  M Tang; A Kemp
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

4.  Impairment of monocytic function after influenza virus infection.

Authors:  M Louie; J Yoo; T Moran; L Mayer; K Sperber
Journal:  Clin Diagn Lab Immunol       Date:  1995-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.